References
- DohnerHWeisdorfDJBloomfieldCDAcute myeloid leukemiaN Engl J Med2015373121136115226376137
- EstellerMEpigenetics in cancerN Engl J Med2008358111148115918337604
- LeyTJDingLWalterMJDNMT3A mutations in acute myeloid leukemiaN Engl J Med2010363252424243321067377
- LinNFuWZhaoCLiBYanXLiYBiologico-clinical significance of DNMT3A variants expression in acute myeloid leukemiaBiochem Biophys Res Commun20174941–227027729024628
- TholFDammFLudekingAIncidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaJ Clin Oncol201129212889289621670448
- GaidzikVIWeberDPaschkaPGerman-Austrian Acute Myeloid Leukemia Study Group (AMLSG)DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaLeukemia2017321303728643785
- SunYShenHXuTPersistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remissionLeuk Res20164910210727626217
- TieRZhangTFuHAssociation between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysisPLoS One201496e9335324936645
- ShivarovVGueorguievaRStoimenovATiuRDNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patientsLeuk Res201337111445145023962568
- LiYZhuBAcute myeloid leukemia with DNMT3A mutationsLeuk Lymphoma20145592002201224283755
- YuanXQPengLZengWJJiangBYLiGCChenXPDNMT3A R882 mutations predict a poor prognosis in AML: a meta-analysis from 4474 patientsMedicine (Baltimore)20169518e351927149454
- BerensteinRBlauIWSuckertNQuantitative detection of DNMT3A R882H mutation in acute myeloid leukemiaJ Exp Clin Cancer Res2015345525994761
- YoheSMolecular genetic markers in acute myeloid leukemiaJ Clin Med20154346047826239249
- ElGDTaalabMMGhazyHFEneenAFDNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndromeBlood Cells Mol Dis2014531–2616624512939
- GaleRELambKAllenCSimpson’s paradox and the impact of different DNMT3A mutations on outcome in younger adults with acute myeloid leukemiaJ Clin Oncol201533182072208325964253
- LeyTJMillerCDingLCancer Genome Atlas Research NetworkGenomic and epigenomic landscapes of adult de novo acute myeloid leukemiaN Engl J Med2013368222059207423634996
- ZhouJDYaoDMLiXXKRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemiaOncotarget2017839660876609729029494
- OhgamiRSMaLMerkerJDNext-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutationsMod Pathol201528570671425412851
- AndradeFGNoronhaEPBrissonGDBrazilian Study Group of Childhood Acute Myeloid Leukemia (IMol-AMLBSG) as coauthorsMolecular characterization of pediatric acute myeloid leukemia: results of a multicentric study in BrazilArch Med Res201647865666728476193
- BacherUHaferlachTSchochCKernWSchnittgerSImplications of NRAS mutations in AML: a study of 2502 patientsBlood2006107103847385316434492
- TholFBollinRGehlhaarMMutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implicationsBlood2014123691492024335498
- HolmbergOKNisterMLindstromMSLoss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcriptionJ Biol Chem201428950346013461925349213
- XuYSunYShenHAllogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutationsAm J Hematol2015901199299726223865
- FrohlingSSchlenkRFBreitruckJAML Study Group UlmAcute myeloid leukemia. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmBlood2002100134372438012393388
- TangSShenHMaoXFLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantationInt J Hematol2017106455256128616699